StockOtters
StockOttersSupply Chain Map
Shanghai RAAS Blood Products Co., Ltd. logo

Shanghai RAAS Blood Products Co., Ltd.

002252.SZ

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
1,145
Cost of Revenue
682
Gross Profit
463
Gross Margin
40.4%
Operating Income
375
Operating Margin
32.8%
Net Income
307
Net Margin
26.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
321
EBITDA Margin
28.0%

2023

12/31/2023

Revenue
1,115
Cost of Revenue
663
Gross Profit
452
Gross Margin
40.5%
Operating Income
312
Operating Margin
27.9%
Net Income
249
Net Margin
22.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
347
EBITDA Margin
31.1%

2022

12/31/2022

Revenue
919
Cost of Revenue
515
Gross Profit
404
Gross Margin
44.0%
Operating Income
319
Operating Margin
34.7%
Net Income
263
Net Margin
28.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
304
EBITDA Margin
33.0%

2021

12/31/2021

Revenue
600
Cost of Revenue
290
Gross Profit
311
Gross Margin
51.7%
Operating Income
218
Operating Margin
36.3%
Net Income
181
Net Margin
30.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
226
EBITDA Margin
37.7%

2020

12/31/2020

Revenue
387
Cost of Revenue
148
Gross Profit
238
Gross Margin
61.6%
Operating Income
210
Operating Margin
54.4%
Net Income
185
Net Margin
47.9%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
164
EBITDA Margin
42.5%